Clinical Trial Update: Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial named GECP-SCAT evaluating customized adjuvant chemotherapy for non-small-cell lung cancer has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Non-small-cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-12-12